Cargando…
Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis
Cyclophilins have important homeostatic roles, but following tissue injury, cyclophilin A (CypA) can promote leukocyte recruitment and inflammation, while CypD can facilitate mitochondrial-dependent cell death. This study investigated the therapeutic potential of a selective cyclophilin inhibitor (G...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795230/ https://www.ncbi.nlm.nih.gov/pubmed/33383945 http://dx.doi.org/10.3390/ijms22010271 |
_version_ | 1783634396191916032 |
---|---|
author | Leong, Khai Gene Ozols, Elyce Kanellis, John Badal, Shawn S. Liles, John T. Nikolic-Paterson, David J. Ma, Frank Y. |
author_facet | Leong, Khai Gene Ozols, Elyce Kanellis, John Badal, Shawn S. Liles, John T. Nikolic-Paterson, David J. Ma, Frank Y. |
author_sort | Leong, Khai Gene |
collection | PubMed |
description | Cyclophilins have important homeostatic roles, but following tissue injury, cyclophilin A (CypA) can promote leukocyte recruitment and inflammation, while CypD can facilitate mitochondrial-dependent cell death. This study investigated the therapeutic potential of a selective cyclophilin inhibitor (GS-642362), which does not block calcineurin function, in mouse models of tubular cell necrosis and renal fibrosis. Mice underwent bilateral renal ischemia/reperfusion injury (IRI) and were killed 24 h later: treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. In the second model, mice underwent unilateral ureteric obstruction (UUO) surgery and were killed 7 days later; treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. GS-642362 treatment gave a profound and dose-dependent protection from acute renal failure in the IRI model. This protection was associated with reduced tubular cell death, including a dramatic reduction in neutrophil infiltration. In the UUO model, GS-642362 treatment significantly reduced tubular cell death, macrophage infiltration, and renal fibrosis. This protective effect was independent of the upregulation of IL-2 and activation of the stress-activated protein kinases (p38 and JNK). In conclusion, GS-642362 was effective in suppressing both acute kidney injury and renal fibrosis. These findings support further investigation of cyclophilin blockade in other types of acute and chronic kidney disease. |
format | Online Article Text |
id | pubmed-7795230 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77952302021-01-10 Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis Leong, Khai Gene Ozols, Elyce Kanellis, John Badal, Shawn S. Liles, John T. Nikolic-Paterson, David J. Ma, Frank Y. Int J Mol Sci Article Cyclophilins have important homeostatic roles, but following tissue injury, cyclophilin A (CypA) can promote leukocyte recruitment and inflammation, while CypD can facilitate mitochondrial-dependent cell death. This study investigated the therapeutic potential of a selective cyclophilin inhibitor (GS-642362), which does not block calcineurin function, in mouse models of tubular cell necrosis and renal fibrosis. Mice underwent bilateral renal ischemia/reperfusion injury (IRI) and were killed 24 h later: treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. In the second model, mice underwent unilateral ureteric obstruction (UUO) surgery and were killed 7 days later; treatment with 10 or 30 mg/kg/BID GS-642362 (or vehicle) began 1 h before surgery. GS-642362 treatment gave a profound and dose-dependent protection from acute renal failure in the IRI model. This protection was associated with reduced tubular cell death, including a dramatic reduction in neutrophil infiltration. In the UUO model, GS-642362 treatment significantly reduced tubular cell death, macrophage infiltration, and renal fibrosis. This protective effect was independent of the upregulation of IL-2 and activation of the stress-activated protein kinases (p38 and JNK). In conclusion, GS-642362 was effective in suppressing both acute kidney injury and renal fibrosis. These findings support further investigation of cyclophilin blockade in other types of acute and chronic kidney disease. MDPI 2020-12-29 /pmc/articles/PMC7795230/ /pubmed/33383945 http://dx.doi.org/10.3390/ijms22010271 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Leong, Khai Gene Ozols, Elyce Kanellis, John Badal, Shawn S. Liles, John T. Nikolic-Paterson, David J. Ma, Frank Y. Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis |
title | Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis |
title_full | Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis |
title_fullStr | Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis |
title_full_unstemmed | Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis |
title_short | Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis |
title_sort | cyclophilin inhibition protects against experimental acute kidney injury and renal interstitial fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795230/ https://www.ncbi.nlm.nih.gov/pubmed/33383945 http://dx.doi.org/10.3390/ijms22010271 |
work_keys_str_mv | AT leongkhaigene cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis AT ozolselyce cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis AT kanellisjohn cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis AT badalshawns cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis AT lilesjohnt cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis AT nikolicpatersondavidj cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis AT mafranky cyclophilininhibitionprotectsagainstexperimentalacutekidneyinjuryandrenalinterstitialfibrosis |